Circle

Right to Choose Changes - The Latest Update on NHS ADHD Services

March 25, 2025

queues to receive adhd diagnosis and treatment due to right to choose changes

Impact on ADHD Assessment Services - Coming April 2025

Increased Waiting Times and Reduced Capacity

The proposed changes will restrict each NHS contracted provider to 25–40 patients per area, drastically reducing assessment capacity. This reduction is expected to extend ADHD assessment waiting times from a few months to several years, placing additional pressure on already overstretched services and risking severe delays in both initial assessments and ongoing reviews.

Disruption in Treatment Continuity

Patients currently benefiting from the Right to Choose may lose access to their established care pathways. With local Integrated Care Boards determining service access based on capped expenditures, many individuals could face a forced return to local wait lists, interrupting medication reviews and long-term treatment continuity.

What This Means for ADHD Patients

If these changes are implemented, the ability to seek an ADHD assessment pathway outside of one’s local NHS region will be severely restricted. Patients who would have previously been referred for private ADHD assessment under NHS funding will now face extensive waiting lists in their area, forcing many to seek private ADHD treatment directly.

Additionally, ADHD medication for children and adults could become harder to obtain due to reductions in available services. Those who rely on annual medication reviews may find their prescriptions delayed or discontinued due to provider constraints.

Book a Private ADHD Assessment to skip the NHS waiting lines

Hidden Bureaucratic Changes in NHS Policy

Ambiguity in Payment Scheme Adjustments

A single, subtle clause embedded in the NHS Payment Scheme Policy is set to transform patient choice. By limiting provider capacity through financial capping—restricting each provider to an expenditure of approximately £100k per area—this technical amendment creates a mirage of choice while effectively curtailing access to critical ADHD services.

Limited Public Consultation and Transparency

The consultation process has been criticized for its lack of clarity and limited public engagement. The approach bypasses robust debate in Parliament, instead relying on a backwater consultation that fails to adequately inform or involve the public. This lack of transparency compromises the democratic principles embedded in the NHS Constitution, leaving patients with diminished rights and minimal avenues for redress.

Political and Stakeholder Response

Critique of the Consultation Process

Stakeholders argue that the current consultation mechanism is insufficient, with its misleading forms and constrained response options. The process restricts individual voices in favor of responses from “qualified” organisations, undermining the democratic accountability of decisions that directly affect patient care.

Political Statements and Advocacy

Political leaders and advocates have expressed strong reservations about the impending changes. Prominent voices in Parliament highlight the risk of extended waiting lists and deteriorating service quality, urging immediate action to safeguard patient choice. The political dialogue centers on restoring full public consultation and ensuring that any future amendments are subject to comprehensive parliamentary debate.

Timeline and Policy Implementation Details

Key Milestones in the Proposed Changes

Implementation of the new terms is scheduled for April 1, with immediate effects expected as providers are informed of their new service limits within the same month. This rapid rollout strategy raises concerns over the feasibility of managing patient backlogs and ensuring service continuity.

Strategic Implications for NHS Services

The swift imposition of these restrictions is designed to streamline provider costs, yet it risks exacerbating regional inequalities. By curtailing the Right to Choose, the policy may force more patients into local services that are already overwhelmed, thereby deepening disparities in access to ADHD assessments and treatment across England.

Practical Guidance for Patient Action

How to Effectively Protest and Engage

Patients and advocates are urged to take immediate action by contacting their local MPs. Writing personalized emails and engaging with established protest channels are essential steps to highlight the detrimental impacts of these changes. Grassroots mobilisation remains critical to ensure that the true cost of reduced patient choice is recognized at all levels of government.

Importance of Direct Political Engagement

Direct engagement with political representatives is vital in defending the constitutional right to NHS choice. By demanding a full and transparent consultation process, affected individuals can help safeguard access to timely ADHD assessments and comprehensive care. Active participation in these debates ensures that patient voices are heard and considered in policy revisions.

FAQs

What does the proposed change mean for ADHD assessments?
The policy limits each provider to a small number of patients, resulting in dramatically increased waiting times and reduced access to essential ADHD assessments.

How might patient treatment continuity be affected?
The new restrictions could force patients off established care pathways, leading to disruptions in medication reviews and long-term treatment plans.

What actions can patients take to oppose these changes?
Patients should contact their MPs and participate in protest efforts to demand a more transparent and comprehensive consultation process that protects their NHS rights.

Book Appointment
Arrow icon in blue circle